<DOC>
	<DOCNO>NCT02489292</DOCNO>
	<brief_summary>The aim study assess efficacy HepaStem treatment paediatric patient suffer urea cycle disorder .</brief_summary>
	<brief_title>Study Evaluate Efficacy HepaStem Urea Cycle Disorders Paediatric Patients ( HEP002 )</brief_title>
	<detailed_description />
	<mesh_term>Disease</mesh_term>
	<mesh_term>Urea Cycle Disorders , Inborn</mesh_term>
	<criteria>Main Paediatric patient &lt; 12 year prior infusion Patient present UCD Patient show patency portal vein branch , normal flow velocity confirm Doppler US accessibility portal vein /or affluants . Main Patient mild disease severity , easily control standard care therapy , recurrent metabolic crisis . Patient register liver transplant wait list schedule live donor liver transplantation end study . Patient present acute liver failure . Patient present clinical radiological evidence liver cirrhosis . Patient present history hepatic extrahepatic malignancy . Patient know clinically significant cardiac malformation . Patient personal history venous thrombosis , clinically significant abnormal value protein S , protein C , antithrombin III , /or activate Protein C Resistance ( aPCR ) screening . In case know family history , complete coagulation workup perform . In described case , result need discussed PB enrol patient study . Patient renal insufficiency treat dialysis .</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>12 Years</maximum_age>
	<verification_date>August 2016</verification_date>
	<keyword>Urea Cycle Disorder</keyword>
	<keyword>UCD</keyword>
	<keyword>cell therapy</keyword>
	<keyword>stem cell</keyword>
</DOC>